companiesandmarkets.com

Return to Report | Print

GTC Biotherapeutics Inc - Premium Company Profile

http://www.companiesandmarkets.com/Summary-Company-Profile/gtc-biotherapeutics-inc-premium-company-profile-41252.asp

Report Summary

Introduction

GTC Biotherapeutics is engaged in the development, production and commercialization of therapeutic proteins expressed and purified from the milk of transgenic animals such as goats and cattle. ATryn, the company's major product, is a recombinant human antithrombin produced in the milk of transgenic goats.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Highlights

    GTC develops, produces, and commercializes therapeutic proteins through transgenic animal technology. In addition to ATryn, GTC is working with LFB Biotechnologies to develop recombinant forms of human factor VIIa and a CD20 monoclonal antibody.

    Total revenues of the company witnessed decline at a CAGR of 11% during 2002-2006, from $10 million to $6 million. It derives its revenues from collaborative agreements which include non-refundable license fees, funding of research and development, payments based upon the achievement of certain milestones and royalties.

    Between 2006 and 2010, the company's revenues are forecasted to increase at a CAGR of 22% from $6 million to $13 million. There will be an absolute growth of +$7 million in the company's total revenues by 2010. The company is expected to receive all of its revenues through collaborative agreements with its partners.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    TABLE OF CONTENTS
    Overview 1
    Catalyst 1
    Summary 1
    Company Structure 6
    Company Overview and Key Facts 6
    Business Description 7
    History 9
    Company Financials 11
    Stock Market Performance 11
    P&L 12
    Balance Sheet 15
    Cash Flow 15
    Business Segment Performance 16
    Products & Services 17
    Pipeline Products 17
    AC Forecast Product Sales 20
    Competitors and Strategic Business Relationships 21
    Key Competitors 21
    Key Suppliers 22
    Key Clients 22
    Shareholding Structure 23
    Strategy 24
    Company View 24
    Corporate Strategy 29
    SWOT Analysis 30
    Overview 30
    Strengths 31
    Weaknesses 32
    Opportunities 33
    Threats 34
    Value Chain Analysis 35
    Overview 35
    Discovery and Product Development 35
    Manufacturing 36
    Scorecard 37
    Overview 37
    Scorecard Analysis 38
    Key Employees 39
    List of Key Employees 39
    Key Employee Biographies 40
    Financial and Operational Overview 45
    Financial and Operational Overview 45
    APPENDIX 48
    Ask the analyst 48
    Datamonitor consulting 48
    Disclaimer 48


    TABLE OF FIGURES
    Figure 1: GTC Biotherapeutics - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 13


    TABLE OF TABLES
    Table 1: GTC Biotherapeutics - Key Facts 6
    Table 2: GTC Biotherapeutics - Year-End Share Price and Market Capitalization, 2002-2006 ($) 11
    Table 3: GTC Biotherapeutics - Key Events Impacting Share Price Performance 11
    Table 4: GTC Biotherapeutics - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 12
    Table 5: GTC Biotherapeutics - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 14
    Table 6: GTC Biotherapeutics - Balance Sheet, 2002-2006 ($ Mn) 15
    Table 7: GTC Biotherapeutics - Cash Flow, 2002-2006 ($ Mn) 15
    Table 8: GTC Biotherapeutics - Revenue Breakdown, 2002-2006 ($ Mn) 16
    Table 9: GTC Biotherapeutics – In-house Pipeline Products 17
    Table 10: GTC Biotherapeutics - Collaboration Pipeline 18
    Table 11: GTC Biotherapeutics- Key Strategic Revenues, 2006-2010 ($ Mn) 20
    Table 12: GTC Biotherapeutics - Key Competitors 22
    Table 13: GTC Biotherapeutics - Key Suppliers 22
    Table 14: GTC Biotherapeutics - Key Clients 22
    Table 15: GTC Biotherapeutics - Key Shareholders 23
    Table 16: GTC Biotherapeutics - SWOT Analysis Summary 30
    Table 17: GTC Biotherapeutics – Value Chain Analysis 35
    Table 18: GTC Biotherapeutics – Scorecard 37
    Table 19: GTC Biotherapeutics - Key Employees 39
    Table 20: GTC Biotherapeutics - Financial and Operational Overview 46